News

La Jolla Pharmaceutical Company, a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering…
Read More...

PCI Pharma Services (PCI) has solidified its leadership position in the EU with strategic investment to deepen its presence in Ireland and expand its European foothold. PCI has…
Read More...

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, announced that Immatics…
Read More...

HiFiBiO Therapeutics, a pioneer in innovative biotherapeutics with a unique single-cell analytics platform for extensive immune profiling, announced the completion of a $67 Million…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Fasenra (benralizumab) for the treatment of eosinophilic oesophagitis…
Read More...

Lannett Company announced that it has entered into an agreement with Sinotherapeutics Inc., a China-based specialty pharmaceutical company, to be the exclusive U.S. distributor of…
Read More...

Viralgen and AskBio announced that Viralgen has received Current Good Manufacturing Practices (cGMP) compliance accreditation and Pharmaceutical Laboratory authorization by the AEMPS…
Read More...

Ionis Pharmaceuticals, the leader in RNA-targeted therapeutics, announced today that GSK exercised its option to license Ionis' antisense medicines for people with chronic hepatitis B…
Read More...

Alvotech and Prestige Biopharma announced a new contract manufacturing partnership for one of Prestige Biopharma´s biosimilar candidates. Alvotech’s Contract Services have been…
Read More...

Machavert Pharmaceuticals, a preclinical stage pharmaceutical company focused on precision medicine cancer therapies, announced that it has obtained a full exclusive license on RAL…
Read More...

Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, and Noile-Immune Biotech, Inc., Tokyo, Japan, a biotechnology company focusing on the development of innovative…
Read More...

Bristol-Myers Squibb Company announced that the European Commission (EC) has approved Empliciti (elotuzumab) plus pomalidomide and low-dose dexamethasone (EPd) for the treatment of…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to delay the progression of renal…
Read More...

The U.S. Food and Drug Administration approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD)…
Read More...

The WIRB-Copernicus Group's (WCG) Clinical Services Division introduces Velos eResearch eXpress, an out-of-the-box, cloud-based solution that enables clinical research sites to…
Read More...

Mustang Bio, Inc. announced that it has entered into a license agreement with CSL Behring for the Cytegrity stable producer cell line developed and used by St. Jude Children’s Research…
Read More...

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and Freenome, a biotechnology company that…
Read More...

Johnson & Johnson and its Janssen Pharmaceutical Companies announced they will appeal the $572 million civil judgment entered in Cleveland County District Court in the State of…
Read More...

Zogenix, Inc. announced that it has entered into a definitive agreement to acquire Modis Therapeutics, Inc., a privately held biopharmaceutical company focused on developing novel…
Read More...

GlaxoSmithKline plc announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare seeking marketing approval for daprodustat, an oral…
Read More...